[1]
K. R. T. Q. A. S. M. N. N. N. ud D. Kashif Rauf, Tehmina Qamar,Bashir Ahmad, Shoaib Malik, Nadeem Naseem, Naseer ud Din, “Effects on ALT normalization in the first month of treatment by Sofosbuvir/Ribavirin therapy versus Sofosbuvir/Daclatasvir therapy in HCV infected individuals”, JRMC, vol. 23, no. 4, Dec. 2019.